Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bijay Mukherji
Current Status of Chimeric Antigen Receptor Engineered T Cell-Based and Immune Checkpoint Blockade-Based Cancer Immunotherapies
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy
JAMA Oncology
Cancer Research
Oncology
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Selinexor‐based Regimens for the Treatment of Myeloma Refractory to Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology
Hematology
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer
American Journal of Hematology
Hematology
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Cancer Cell
Cancer Research
Oncology
Cell Biology